Total Revenue |
2.29T |
1.21T |
1.02T |
Cost of Revenue |
0 |
0 |
0 |
Gross Profit |
2.29T |
1.21T |
1.02T |
Operating Expenses |
466.65B |
515.34B |
403.12B |
Research and Development |
0 |
0 |
0 |
Selling, General & Administrative Expenses |
951.76B |
400.22B |
320.22B |
Selling & Marketing Expenses |
0 |
2.7B |
2.63B |
General & Administrative Expenses |
951.76B |
400.22B |
320.22B |
Other Expenses |
0 |
-269.95B |
-209.62B |
Operating Income |
1.82T |
589.98B |
490.94B |
Total Other Income/Expenses Net |
-1.06T |
902.1M |
645.8M |
Income Before Tax |
765.69B |
662.38B |
519.16B |
Income Tax |
111.22B |
166.12B |
132.56B |
Net Income |
640.62B |
495.45B |
386B |
Basic EPS |
90.01 |
89.02 |
69.76 |
EPS Diluted |
90.01 |
88.68 |
69.38 |
Basic Average Shares |
7.12B |
7.59B |
7.59B |
Diluted Average Shares |
7.12B |
7.59B |
7.59B |
EBITDA |
0 |
638.47B |
525.55B |